A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000037:antagonists & inhibitors; D000328:Adult; D000368:Aged; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use*; D002415:Cats; D003000:Clonidine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008722:Methods; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000517:prevention & control; D010869:Pindolol / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D007211:Indoles; D014662:Vasoconstrictor Agents; D002220:Carbamazepine; D010869:Pindolol; D003000:Clonidine